Suppr超能文献

[慢性抑制一氧化氮合成诱导高血压的机制]

[Mechanism mediating hypertension induced by chronic inhibition of nitric oxide synthesis].

作者信息

Li X, Yuasa S, Hitomi H, Hashimoto M, Fujioka H, Kiyomoto H, Uchida K, Shoji T, Takahashi N, Matsuo H

机构信息

Second Department of Internal Medicine, School of Medicine, Kagawa Medical University, Japan.

出版信息

Nihon Jinzo Gakkai Shi. 1997 Oct;39(7):718-27.

PMID:9396239
Abstract

Although the inhibition of nitric oxide (NO) synthesis is known to induce systemic hypertension, the underlying mechanisms mediating this type of hypertension are incompletely understood. In the present study we investigated the influence of sodium intake on the pressor effect of long-term administration of the NO synthesis inhibitor, NG-nitro-L-arginine methyl ester (L-NAME, 16 mg/dl in drinking fluid for 8 weeks), in conscious Sprague-Dawley rats. Urinary excretion rates of catecholamine during NO synthesis inhibition were also examined. Long-term administration of L-NAME produced a sustained elevation in tail-cuff pressure without altering urine flow, or sodium excretion rate. L-NAME-induced hypertension was accompanied by a decreased urinary excretion of the stable NO metabolites, NO2- and NO3-, and was aggravated when rats drank 0.9% saline in place of tap water. Thus, inhibition of NO synthesis resulted in a rightward shift of the pressure natriuresis relationship and a significant decrease in the slope of this relationship. Urinary excretion of epinephrine and norepinephrine, but not that of dopamine, in L-NAME-treated rats significantly increased within the first week of the study when compared with those observed in control rats. A natriuretic index of the sympathetic nervous system, the ratio of dopamine to norepinephrine excretion, was significantly less in L-NAME-treated rats than in control rats. After 8-week treatment with L-NAME, renal morphologic evaluation revealed significant narrowing and obliteration of the arterioles. L-arginine (2 g/dl in drinking fluid) completely reversed the elevation of blood pressure as well as the decrease in urinary NO2- and NO3- excretion and the increased urinary excretion of catecholamines associated with L-NAME treatment after 3 weeks of concomitant administration. These results suggest that the inhibition of chronic NO synthesis produces sodium-sensitive hypertension and that changes in sympathetic nerve activity may, at least in part, contribute to the sodium sensitivity in this type of hypertension.

摘要

尽管已知抑制一氧化氮(NO)合成会诱发全身性高血压,但介导此类高血压的潜在机制仍未完全明确。在本研究中,我们调查了钠摄入量对清醒的Sprague-Dawley大鼠长期给予NO合成抑制剂NG-硝基-L-精氨酸甲酯(L-NAME,饮水中含16 mg/dl,持续8周)的升压作用的影响。同时还检测了NO合成抑制期间儿茶酚胺的尿排泄率。长期给予L-NAME可使尾套压持续升高,而尿流量和钠排泄率未发生改变。L-NAME诱发的高血压伴有稳定的NO代谢产物NO2-和NO3-的尿排泄减少,当大鼠饮用0.9%盐水而非自来水时,高血压会加重。因此,抑制NO合成导致压力-利钠关系向右移位,且该关系的斜率显著降低。与对照大鼠相比,L-NAME处理的大鼠在研究的第一周内肾上腺素和去甲肾上腺素的尿排泄显著增加,但多巴胺的尿排泄无明显变化。交感神经系统的利钠指数,即多巴胺与去甲肾上腺素排泄的比值,在L-NAME处理的大鼠中显著低于对照大鼠。用L-NAME治疗8周后,肾脏形态学评估显示小动脉明显狭窄和闭塞。同时给予L-精氨酸(饮水中含2 g/dl)3周后,可完全逆转与L-NAME治疗相关的血压升高、尿中NO2-和NO3-排泄减少以及儿茶酚胺尿排泄增加的情况。这些结果表明,慢性抑制NO合成会产生钠敏感性高血压,并且交感神经活动的变化可能至少部分导致了此类高血压中的钠敏感性。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验